Charles River acquires K.F. (Cambodia) Ltd.

Charles River agreed to acquire K.F. (Cambodia) Ltd.. Reported deal value: $510M. Status: Pending. Sector: Biomedical Research. Target headquarters context: Location not specified.

This page summarizes publicly available information about the transaction as of 2026-01-13. Figures and status may change as filings and press coverage update.

Charles River Laboratories International Inc. unveiled a series of strategic moves at the J.P. Morgan 44th Annual Healthcare Conference, including two planned acquisitions , a key leadership appointment , and an update on recent business trends with a preliminary outlook for 2026